Home >> About

News & Events

PHILADELPHIA--(BUSINESS WIRE)--Four promising technologies are one step closer to the marketplace thanks to funding from the University City Science Center’s QED Proof-of-Concept Program. Life science and health IT researchers from Drexel University, Temple University and Rutgers, The State University of New Jersey, received a total of $600,000 through the QED program to develop a potential drug therapy for Lou Gehrig’s disease; validate a new therapeutic compound for pancreatic cancer; develop software to analyze EEG readings and guide diagnosis; and improve communications skills of health care professionals.

We are pleased to announce internal grant awards for four drug discovery research projects to be conducted by groups of Temple faculty members. These awards are part of the Temple University Drug Discovery Initiative established in 2010 to encourage and support collaborative research with the Moulder Center for Drug Discovery Research in the School of Pharmacy.

Dr. Magid Abou-Gharbia has been appointed a Laura H. Carnell Professor, Temple University’s highest professorial honorific, effective July 1, 2013.

During the recent Temple Duquesne basketball game, Dr. Magid Abou-Gharbia, Professor of Medicinal Chemistry & Associate Dean for Research and Director of the Moulder Center and Dr. Nicole Sifontis, Clinical Associate Professor of Pharmacy Practice, were recognized by the Department of Athletics, for their extraordinary contributions to teaching, service and scholarship.

Started five years ago with the support of alumnus Lonnie Moulder and his wife, Sharon, the Moulder Center for Drug Discovery Research in the School of Pharmacy has grown to become the Greater Philadelphia region’s only fully integrated academic drug discovery center.

Dotmatics Limited, a leading provider of informatics solutions to the pharmaceutical and biotechnology industries, today announced that The Moulder Centre for Drug Discovery Research at Temple University have licensed Dotmatics’ suite of solutions to boost their drug discovery research efforts.

An innovative funding model designed to promote interdepartmental collaboration with the Moulder Center for Drug Discovery Research in Temple’s School of Pharmacy is already showing results.

Dr Magid Abou-Gharbia, Associate Dean for Research, Professor & Director, Moulder Center for Drug Discovery Research, School of Pharmacy, Temple University and formerly Senior VP of Wyeth, Head of Chemical & Screening Processes, will chair a roundtable panel discussion at the ChemSpec India 2013 Meeting.

Panel discussions on supplying services to the drug industry at Chemspec conferences this summer featured executives from companies one would expect to find on such panels. The chief executives of contract service firms and outsourcing managers at top drug companies discussed changes in science and business that are creating opportunities in contract R&D and manufacturing.

A more surprising participant on these panels was the moderator: Magid Abou-Gharbia, director of the Moulder Center for Drug Discovery Research at Temple University’s School of Pharmacy. Still best known in the industry as the former head of chemical and screening sciences at Wyeth, Abou-Gharbia now directs an up-and-comer in the field of academic drug discovery. At the center, he is a proponent for expanding a facet of scientific research that was once anathema in academia: the business model.

Compared to the recent rocky roads of other U.S. industries — such as the automotive industry—the field of prescription drugs might appear to be holding its own: The IMS Institute for Healthcare Informatics reported its total 2010 sales to be more than $307 billion.

What that number does not reveal is that big pharma suffers from an “innovation gap,” the amount of products—or rather, lack thereof— coming through the industry pipeline.  In 1996, the industry hit its peak, with 56 new drugs approved for consumer use by the U.S. Food and Drug Administration. Since then, new drug approvals have steadily declined to as few as 18 per year.


Temple University
Moulder Center for Drug Discovery Research

Temple University School of Pharmacy
3307 N Broad Street
Philadelphia, PA 19140